Whitehawk Therapeutics Files 8-K/A Amendment
Ticker: WHWK · Form: 8-K/A · Filed: Mar 31, 2025 · CIK: 1422142
| Field | Detail |
|---|---|
| Company | Whitehawk Therapeutics, INC. (WHWK) |
| Form Type | 8-K/A |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Whitehawk Therapeutics (formerly Aadi Bioscience) filed an 8-K/A amendment on 3/31/25 for an event on 3/25/25.
AI Summary
Whitehawk Therapeutics, Inc. filed an 8-K/A on March 31, 2025, to amend a previous filing. The amendment pertains to Item 9.01, Financial Statements and Exhibits, related to an event that occurred on March 25, 2025. The company, formerly known as Aadi Bioscience, Inc., is incorporated in Delaware and headquartered in Morristown, NJ.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be significant for investors tracking the company's disclosures.
Risk Assessment
Risk Level: low — This is a routine amendment filing (8-K/A) that corrects or adds to previous disclosures, rather than announcing a new material event.
Key Numbers
- 001-38560 — SEC File Number (Identifies the company's filing history with the SEC)
- 61-1547850 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Whitehawk Therapeutics, Inc. (company) — Registrant
- Aadi Bioscience, Inc. (company) — Former company name
- March 25, 2025 (date) — Date of earliest event reported
- March 31, 2025 (date) — Date of report
- Morristown, New Jersey (location) — Company headquarters
FAQ
What specific information is being amended in the 8-K/A filing?
The filing is an amendment to Item 9.01, Financial Statements and Exhibits, indicating that the amendment pertains to financial statements and/or exhibits previously filed.
What was the original event date that this amendment relates to?
The earliest event reported, which this amendment relates to, occurred on March 25, 2025.
When was this 8-K/A filing submitted to the SEC?
The filing was submitted on March 31, 2025.
What is the current name of the company filing this report?
The current name of the company is Whitehawk Therapeutics, Inc.
What were some of the former names of Whitehawk Therapeutics, Inc. mentioned in the filing?
The filing mentions former names including Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., and ZETA ACQUISITION CORP II.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on March 31, 2025 regarding Whitehawk Therapeutics, Inc. (WHWK).